The European Medicines Agency says that it is putting certain lower-priority activities on hold and may need to divert resources away from activities planned for 2018 so that it can prepare for its Brexit-related relocation and focus on its core tasks.
Keeping its operations running smoothly and retaining as many staff as possible during the move is a key priority for...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?